Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired in Macro…Update-4…rally in spec biotechs!
Update-4...1/6/23...Broad rally sparked by latest economic data anticipating weaker economy and slowing wage growth . Bond yields are down. A '"soft landing '"scenario? We are at the JPMorgan Healthcare Conference next week. Closing trades: XLV at $135.67, IBB at $133.14, XBI at $83.16...
Biotech Momentum Wanes in Choppy Trading..Update-2…After FED
Update-2 Powell Reiterates Need To Fight Inflation The FED raised rates 50 bpts and Powell said more rate increases are coming, ( but aren't we getting close to the top?). Stocks ended lower,NAZ down 0.75%, with gyrations in last 30 minute of trading. It was pretty much as expected but the two...
Uncertainty Grips Markets-On A Clear Day, Maybe You Can See a Week Ahead
Uncertainty Grips Markets- But December Still Looks Good Major Indices are down as of 11 am trading amid protest in China.Apple (AAPL) is down over 2% on potential production shortfall from Foxconn.The XBI is flat at thee $81 level but large caps are strong and the IBB continues its run from...
Large Cap Biopharmaceuticals 2022: Market Performance and Metrics…Update-1 rally time
Update-1 11/22 Broad Market Rally with all major indices up over 1%. Small cap spec stocks gain momentum, XBI up 1.38%. Energy materials and tech strong. IBB up 0.79% to $134. Bears acknowledge year end strength but still say 2023 fraught with weakening economy and uncertainty on earnings...
Healthcare Sectors Update-Time to Review Your Portfolio…Update-1
Update-1 11/18...Healthcare stocks had a good week with the XLV up almost 1% to $134 despite choppiness. We are still facing MACRO headwinds and the FED so stay cautious. There was good tape action in mid-cap biopharmas. Medtech is looking better with the IHI up 4% for the week but the sector...